Neonatal Hipoksik-İskemik Ensefalopati’de Nöroprotektif Tedavi Seçenekleri

Executive Summary. Obstetrics & Gynecology. 2014 Apr;123(4):896–901.

Molloy EJ, Bearer C. Neonatal encephalopathy versus Hypoxic-Ischemic Encephalopathy. Pediatr Res. 2018 Nov 7;84(5):574–574.

Russ JB, Simmons R, Glass HC. Neonatal Encephalopathy: Beyond Hypoxic-Ischemic Encephalopathy. Neoreviews. 2021 Mar 1;22(3):e148–62.

Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic–ischaemic encephalopathy. Early Hum Dev. 2010 Jun;86(6):329–38.

Bonifacio SL, Hutson S. The Term Newborn. Clin Perinatol. 2021 Aug;48(3):681–95.

Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic–ischaemic encephalopathy. Early Hum Dev. 2010 Jun;86(6):329–38.

Shankaran S. Neonatal Encephalopathy: Treatment with Hypothermia. J Neurotrauma. 2009 Mar;26(3):437–43.

de Vries LS, Cowan FM. Evolving Understanding of Hypoxic-Ischemic Encephalopathy in the Term Infant. Semin Pediatr Neurol. 2009 Dec;16(4):216–25.

Kumar S, Paterson-Brown S. Obstetric aspects of hypoxic ischemic encephalopathy. Early Hum Dev. 2010 Jun;86(6):339–44.

Cotten CM, Shankaran S. Hypothermia for hypoxic–ischemic encephalopathy. Expert Rev Obstet Gynecol. 2010 Mar 10;5(2):227–39.

Shalak L, Perlman JM. Hypoxic–ischemic brain injury in the term infant-current concepts. Early Hum Dev. 2004 Nov;80(2):125–41.

Hanrahan JD, Sargentoni J, Azzopardi D, Manji K, Cowan FM, Rutherford MA, et al. Cerebral Metabolism within 18 Hours of Birth Asphyxia: A Proton Magnetic Resonance Spectroscopy Study. Pediatr Res. 1996 Apr;39(4):584–90.

Fatemi A, Wilson MA, Johnston M V. Hypoxic-Ischemic Encephalopathy in the Term Infant. Clin Perinatol. 2009 Dec;36(4):835–58.

Buonocore G, Groenendaal F. Anti-oxidant strategies. Semin Fetal Neonatal Med. 2007 Aug;12(4):287–95.

Ferriero DM. Neonatal Brain Injury. New England Journal of Medicine. 2004 Nov 4;351(19):1985–95.

Inder TE, Volpe JJ. Hypoxic-Ischemic Injury in the Term Infant. In: Volpe’s Neurology of the Newborn. Elsevier; 2018. p. 510-563.e15.

Martinello K, Hart AR, Yap S, Mitra S, Robertson NJ. Management and investigation of neonatal encephalopathy: 2017 update. Arch Dis Child Fetal Neonatal Ed. 2017 Jul;102(4):F346–58.

Inder TE, Volpe JJ. Intrauterine, Intrapartum Assessments in the Term Infant. In: Volpe’s Neurology of the Newborn. Elsevier; 2018. p. 458-483.e8.

Liljestrom L, Wikstrom A, Jonsson M. Obstetric emergencies as antecedents to neonatal hypoxic ischemic encephalopathy, does parity matter? Acta Obstet Gynecol Scand. 2018 Nov 2;97(11):1396–404.

Wachtel E V., Verma S, Mally P V. Update on the current management of newborns with neonatal encephalopathy. Curr Probl Pediatr Adolesc Health Care. 2019 Jul;49(7):100636.

Broni EK, Eke AC, Vaidya D, Tao X, Northington FJ, Everett AD, et al. Blood biomarkers for neonatal hypoxic–ischemic encephalopathy in the presence and absence of sentinel events. Journal of Perinatology. 2021 Jun 6;41(6):1322–30.

Dixon B, Reis C, Ho W, Tang J, Zhang J. Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy. Int J Mol Sci. 2015 Sep 15;16(9):22368–401.

Martinez-Biarge M, Diez-Sebastian J, Wusthoff CJ, Mercuri E, Cowan FM. Antepartum and Intrapartum Factors Preceding Neonatal Hypoxic-Ischemic Encephalopathy. Pediatrics. 2013 Oct 1;132(4):e952–9.

Yeh P, Emary K, Impey L. The relationship between umbilical cord arterial pH and serious adverse neonatal outcome: analysis of 51 519 consecutive validated samples. BJOG. 2012 Jun 10;119(7):824–31.

Prempunpong C, Chalak LF, Garfinkle J, Shah B, Kalra V, Rollins N, et al. Prospective research on infants with mild encephalopathy: the PRIME study. Journal of Perinatology. 2018 Jan 2;38(1):80–5.

Murray DM, O’Connor CM, Ryan CA, Korotchikova I, Boylan GB. Early EEG Grade and Outcome at 5 Years After Mild Neonatal Hypoxic Ischemic Encephalopathy. Pediatrics. 2016 Oct 1;138(4).

Chalak L, Latremouille S, Mir I, Sánchez PJ, Sant’Anna G. A review of the conundrum of mild hypoxic-ischemic encephalopathy: Current challenges and moving forward. Early Hum Dev. 2018 May;120:88–94.

Korf JM, McCullough LD, Caretti V. A narrative review on treatment strategies for neonatal hypoxic ischemic encephalopathy. Transl Pediatr. 2023 Aug;12(8):1552–71.

Bonifacio SL, Chalak LF, Van Meurs KP, Laptook AR, Shankaran S. Neuroprotection for hypoxic-ischemic encephalopathy: Contributions from the neonatal research network. Semin Perinatol. 2022 Nov;46(7):151639.

Tagin M, Shah PS, Lee KS. Magnesium for newborns with hypoxic-ischemic encephalopathy: a systematic review and meta-analysis. Journal of Perinatology. 2013 Sep 6;33(9):663–9.

Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews. 2013 Jan 31;

El-Dib M, Inder TE, Chalak LF, Massaro AN, Thoresen M, Gunn AJ. Should therapeutic hypothermia be offered to babies with mild neonatal encephalopathy in the first 6 h after birth? Pediatr Res. 2019 Mar 16;85(4):442–8.

Goswami IR, Whyte H, Wintermark P, Mohammad K, Shivananda S, Louis D, et al. Characteristics and short-term outcomes of neonates with mild hypoxic-ischemic encephalopathy treated with hypothermia. Journal of Perinatology. 2020 Feb 13;40(2):275–83.

Lemyre B, Chau V. Hypothermia for newborns with hypoxic-ischemic encephalopathy. Paediatr Child Health. 2018 Jun 12;23(4):285–91.

Hakobyan M, Dijkman KP, Laroche S, Naulaers G, Rijken M, Steiner K, et al. Outcome of Infants with Therapeutic Hypothermia after Perinatal Asphyxia and Early-Onset Sepsis. Neonatology. 2019;115(2):127–33.

Joanna R. G. V, Lopriore E, te Pas AB, Rijken M, van Zwet EW, de Bruine FT, et al. Persistent pulmonary hypertension in neonates with perinatal asphyxia and therapeutic hypothermia: a frequent and perilous combination. The Journal of Maternal-Fetal & Neonatal Medicine. 2022 Nov 30;35(25):4969–75.

Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews. 2013 Jan 31;

Lv H yan, Wu S jing, Wang Q li, Yang L hong, Ren P shun, Qiao B jun, et al. Effect of erythropoietin combined with hypothermia on serum tau protein levels and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy. Neural Regen Res. 2017;12(10):1655.

Wu YW, Comstock BA, Gonzalez FF, Mayock DE, Goodman AM, Maitre NL, et al. Trial of Erythropoietin for Hypoxic–Ischemic Encephalopathy in Newborns. New England Journal of Medicine. 2022 Jul 14;387(2):148–59.

Pluta R, Furmaga-Jabłońska W, Januszewski S, Tarkowska A. Melatonin: A Potential Candidate for the Treatment of Experimental and Clinical Perinatal Asphyxia. Molecules. 2023 Jan 22;28(3):1105.

Fei Q, Wang D, Yuan T. Comparison of Different Adjuvant Therapies for Hypothermia in Neonates with Hypoxic-Ischemic Encephalopathy: A Systematic Review and Network Meta-Analysis. Indian J Pediatr. 2024 Mar 18;91(3):235–41.

Victor S, Rocha-Ferreira E, Rahim A, Hagberg H, Edwards D. New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy. Eur J Pediatr. 2022 Mar 24;181(3):875–87.

Maiwald CA, Annink K V., Rüdiger M, Benders MJNL, van Bel F, Allegaert K, et al. Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): study protocol of a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III). BMC Pediatr. 2019 Dec 27;19(1):210.

Kumar C, Adhisivam B, Bobby Z, Bhat BV. Magnesium Sulfate as an Adjunct to Therapeutic Hypothermia in the Management of Term Infants with Hypoxic–Ischemic Encephalopathy: A Randomized, Parallel-Group, Controlled Trial. Indian J Pediatr. 2023 Sep 18;90(9):886–92.

Azzopardi D, Robertson NJ, Bainbridge A, Cady E, Charles-Edwards G, Deierl A, et al. Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial. Lancet Neurol. 2016 Feb;15(2):145–53.

Tsuji M, Sawada M, Watabe S, Sano H, Kanai M, Tanaka E, et al. Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety. Sci Rep. 2020 Mar 12;10(1):4603.

Cotten CM, Murtha AP, Goldberg RN, Grotegut CA, Smith PB, Goldstein RF, et al. Feasibility of Autologous Cord Blood Cells for Infants with Hypoxic-Ischemic Encephalopathy. J Pediatr. 2014 May;164(5):973-979.e1.

Cotten CM, Fisher K, Malcolm W, Gustafson KE, Cheatham L, Marion A, et al. A Pilot Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates With Hypoxic-Ischemic Encephalopathy. Stem Cells Transl Med. 2023 Jun 15;12(6):355–64.

Kelen D, Robertson NJ. Experimental treatments for hypoxic ischaemic encephalopathy. Early Hum Dev. 2010 Jun;86(6):369–77.

Barks JD, Liu YQ, Shangguan Y, Silverstein FS. Phenobarbital Augments Hypothermic Neuroprotection. Pediatr Res. 2010 May;67(5):532–7.

Schubert S, Brandl U, Brodhun M, Ulrich C, Spaltmann J, Fiedler N, et al. Neuroprotective effects of topiramate after hypoxia–ischemia in newborn piglets. Brain Res. 2005 Oct;1058(1–2):129–36.

Berman DR, Mozurkewich E, Liu Y, Barks J. Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia. Am J Obstet Gynecol. 2009 Mar;200(3):305.e1-305.e6.

Martínez-Orgado J. Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia. Molecular Brain Research. 2003 Jun 10;114(2):132–9.